The closing of the transaction is subject to customary closing conditions, including receipt of regulatory approvals in
In connection with the transaction, KJCC has reached agreement with its largest customer in
Commenting on the sale,
President and Chief Executive Officer
Fourth Quarter 2019 Estimated Financial Performance
While the company is still conducting financial closing procedures for the fourth quarter and full year,
- Estimated consolidated sales were
$393.2 million for the fourth quarter of 2019, a decrease of$32.2 million , or 7.6 percent, from sales of$425.4 million in the prior year quarter. Excluding a negative impact from foreign currency translation of$3.1 million , sales were lower by$29.1 million or 6.9 percent. - Preliminary operating profit was
$24.3 million , or 6.2 percent, compared with$13.6 million , or 3.2 percent, in the prior year quarter. Estimated adjusted EBITDA was$39.0 million , or 9.9 percent, compared with$46.9 million , or 11.0 percent, in the prior year quarter. Operating profit margin and adjusted EBITDA margin are calculated as a percentage of GAAP sales. - Adjustments to preliminary pre-tax income totaled
$0.7 million for the fourth quarter of 2019, compared to$18.3 million for the fourth quarter of 2018. - Preliminary net income attributable to
Koppers for the fourth quarter was$20.6 million , compared to a net loss of$2.6 million in the prior year quarter. - Preliminary adjusted net income was
$6.2 million for the fourth quarter of 2019, compared to$12.4 million in the prior year quarter, respectively. - Preliminary diluted earnings per share (EPS) was
$0.96 , compared with$(0.13) per share in the prior year quarter. Preliminary adjusted EPS for the quarter was$0.29 , compared with$0.60 for the prior year period.
At
Commenting on the results, President and CEO
Mr. Ball continued, "On the positive side, we had a very strong fourth quarter cash flow, which has brought our net debt at year-end to below
About
Safe Harbor Statement
Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and include, but are not limited to, statements concerning the proposed sale of KJCC, the regulatory approvals and other closing conditions required in connection with the transaction and the expected settlement of a customer dispute. All forward-looking statements involve risks and uncertainties. All statements contained herein that are not clearly historical in nature are forward-looking, and words such as "outlook," "guidance," "forecast," "believe," "anticipate," "expect," "estimate," "may," "will," "should," "continue," "plan," "potential," "intend," "likely," or other similar words or phrases are generally intended to identify forward-looking statements. Any forward-looking statement contained herein, in other press releases, written statements or other documents filed with the Securities and Exchange Commission, or in Koppers communications and discussions with investors and analysts in the normal course of business through meetings, phone calls and conference calls, regarding expectations with respect to sales, earnings, cash flows, operating efficiencies, restructurings, the benefits of acquisitions, divestitures, joint ventures or other matters as well as financings and debt reduction, are subject to known and unknown risks, uncertainties and contingencies.
Many of these risks, uncertainties and contingencies are beyond our control, and may cause actual results, performance or achievements to differ materially from anticipated results, performance or achievements. Factors that might affect such forward-looking statements include, among other things, risks associated with the proposed sale of KJCC, including the inability to obtain, or delays in obtaining, the required regulatory and other approvals; the impact of changes in commodity prices, such as oil and copper, on product margins; general economic and business conditions; potential difficulties in protecting our intellectual property; the ratings on our debt and our ability to repay or refinance our outstanding indebtedness as it matures; our ability to operate within the limitations of our debt covenants; potential impairment of our goodwill and/or long-lived assets; demand for Koppers goods and services; competitive conditions; interest rate and foreign currency rate fluctuations; availability and costs of key raw materials; unfavorable resolution of claims against us, as well as those discussed more fully elsewhere in this release and in documents filed with the Securities and Exchange Commission by Koppers, particularly our latest annual report on Form 10-K and quarterly reports on Form 10-Q. Any forward-looking statements in this release speak only as of the date of this release, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after that date or to reflect the occurrence of unanticipated events.
UNAUDITED RECONCILIATION OF OPERATING PROFIT TO EBITDA AND ADJUSTED EBITDA |
||
Three Months Ended December 31, 2019 |
||
(Preliminary) |
||
Operating profit |
$ |
24.3 |
Other income |
0.1 |
|
Depreciation and amortization |
12.8 |
|
Depreciation in impairment and restructuring charges |
0.8 |
|
EBITDA with noncontrolling interest |
$ |
38.0 |
Unusual items impacting EBITDA: |
||
CMC restructuring |
5.4 |
|
Non-cash LIFO expense |
(0.4) |
|
Mark-to-market commodity hedging |
(4.0) |
|
Adjusted EBITDA |
$ |
39.0 |
UNAUDITED RECONCILIATION OF OPERATING PROFIT TO EBITDA AND ADJUSTED EBITDA |
||
Three Months Ended December 31, 2018 |
||
Operating profit |
$ |
13.6 |
Other income |
1.8 |
|
Depreciation and amortization |
12.3 |
|
Depreciation in impairment and restructuring charges |
0.2 |
|
EBITDA with noncontrolling interest |
$ |
27.9 |
Unusual items impacting EBITDA: |
||
CMC restructuring |
10.4 |
|
Non-cash LIFO expense |
6.3 |
|
Mark-to-market commodity hedging |
1.4 |
|
RUPS treating plant closures |
0.8 |
|
Sale of specialty chemicals business |
0.1 |
|
Adjusted EBITDA |
$ |
46.9 |
UNAUDITED RECONCILIATION OF NET INCOME TO EBITDA AND ADJUSTED EBITDA |
||||||||
Three Months Ended December 31, |
||||||||
2019 |
2018 |
|||||||
(Preliminary) |
||||||||
Net income |
$ |
20.2 |
$ |
(2.4) |
||||
Interest expense |
14.3 |
16.2 |
||||||
Depreciation and amortization |
12.8 |
12.3 |
||||||
Depreciation in impairment and restructuring charges |
0.8 |
0.0 |
||||||
Income taxes |
(10.1) |
1.6 |
||||||
EBITDA with noncontrolling interests |
38.0 |
27.7 |
||||||
Unusual items impacting net income |
||||||||
Impairment, restructuring and plant closure costs |
5.4 |
11.3 |
||||||
Non-cash LIFO expense |
(0.4) |
6.3 |
||||||
Mark-to-market commodity hedging |
(4.0) |
1.4 |
||||||
Acquisition closing costs |
0.0 |
0.1 |
||||||
Sale of specialty chemical business |
0.0 |
0.1 |
||||||
Total adjustments |
1.0 |
19.2 |
||||||
Adjusted EBITDA |
$ |
39.0 |
$ |
46.9 |
UNAUDITED RECONCILIATION OF NET INCOME ATTRIBUTABLE TO KOPPERS AND ADJUSTED NET INCOME |
||||||||
Three Months Ended December 31, |
||||||||
2019 |
2018 |
|||||||
(Preliminary) |
||||||||
Net income (loss) attributable to Koppers |
$ |
20.6 |
$ |
(2.6) |
||||
Unusual items impacting net income |
||||||||
Impairment, restructuring and plant closure costs |
5.0 |
10.5 |
||||||
Non-cash LIFO expense |
(0.4) |
6.3 |
||||||
Mark-to-market commodity hedging |
(3.9) |
1.4 |
||||||
Sale of specialty chemical business |
0.0 |
0.1 |
||||||
Total adjustments |
0.7 |
18.3 |
||||||
Adjustments to income tax and noncontrolling interests |
||||||||
Income tax on adjustments to pre-tax income |
(15.1) |
(3.3) |
||||||
Effect on adjusted net income |
(14.4) |
15.0 |
||||||
Adjusted net income attributable to Koppers |
$ |
6.2 |
$ |
12.4 |
UNAUDITED RECONCILIATION OF DILUTED EARNINGS PER SHARE AND |
||||||||
Three Months Ended December 31, |
||||||||
2019 |
2018 |
|||||||
(Preliminary) |
||||||||
Net income (loss) attributable to Koppers |
$ |
20.6 |
$ |
(2.6) |
||||
Adjusted net income |
$ |
6.2 |
$ |
12.4 |
||||
Denominator for diluted earnings per share (in thousands) |
21,369 |
20,511 |
||||||
Earnings per share: |
||||||||
Diluted earnings per share |
$ |
0.96 |
$ |
(0.13) |
||||
Adjusted earnings per share |
$ |
0.29 |
$ |
0.60 |
UNAUDITED RECONCILIATION OF TOTAL DEBT TO NET DEBT AND NET LEVERAGE RATIO |
|||||||||||
Year Ended December 31, |
|||||||||||
Preliminary 2019 |
|
2018 |
|||||||||
Total Debt |
$ |
901.2 |
$ |
990.4 |
$ |
990.4 |
|||||
Less: Cash |
33.0 |
40.6 |
40.6 |
||||||||
Net Debt |
$ |
868.2 |
$ |
949.8 |
$ |
949.8 |
|||||
Adjusted EBITDA |
$ |
210.8 |
$ |
225.7 |
$ |
221.6 |
|||||
Net Leverage Ratio |
4.1 |
4.2 |
4.3 |
UNAUDITED RECONCILIATION OF NET INCOME TO EBITDA AND ADJUSTED EBITDA |
|||||||
December 31, 2019 |
December 31, 2018 |
||||||
(Preliminary) |
|||||||
Net income |
$ |
67.4 |
$ |
29.2 |
|||
Interest expense |
62.6 |
56.3 |
|||||
Depreciation and amortization |
58.5 |
54.8 |
|||||
Income tax provision |
1.4 |
26.0 |
|||||
Income from discontinued operations |
0.0 |
(0.4) |
|||||
EBITDA |
189.9 |
165.9 |
|||||
Unusual items impacting net income: |
|||||||
Impairment, restructuring and plant closure |
20.4 |
23.5 |
|||||
Non-cash LIFO expense |
4.5 |
12.6 |
|||||
Mark-to-market commodity hedging |
(4.0) |
6.9 |
|||||
Sale of specialty chemicals business |
0.0 |
0.9 |
|||||
UIP inventory purchase accounting adjustment |
0.0 |
6.0 |
|||||
Acquisition closing costs |
0.0 |
3.1 |
|||||
Contract buyout |
0.0 |
1.6 |
|||||
Sale of land |
0.0 |
1.1 |
|||||
Adjusted EBITDA with noncontrolling interests |
$ |
210.8 |
$ |
221.6 |
|||
Proforma adjusted EBITDA from acquisitions |
0.0 |
4.1 |
|||||
Proforma adjusted EBITDA with noncontrolling interests |
$ |
210.8 |
$ |
225.7 |
For information: |
Michael J. Zugay, Chief Financial Officer and Treasurer |
412 227 2231 |
|
View original content:http://www.prnewswire.com/news-releases/koppers-announces-agreement-to-sell-china-distillation-business-also-reports-preliminary-fourth-quarter-2019-results-301006498.html
SOURCE